Title: Aloxiprin
CAS Registry Number: 9014-67-9
CAS Name: 2-(Acetyloxy)benzoic acid polymer with aluminum oxide
Additional Names: polyoxyaluminum acetylsalicylate
Trademarks: Lyman (Drossapharm); Palaprin (Nicholas); Rumatral (Nicholas)
Literature References: A polymeric condensation product of aluminum oxide and aspirin. Approx formula, Al3O2[C6H4(OOCCH3)COO]5. Prepd from aluminum isopropoxide and aspirin: Cummings et al., J. Pharm. Pharmacol. 15, 56 (1963).
Properties: Powder with greater bulk density and relatively low free salicylic acid content as compared with other aluminum salicylates. Rates of soln of aspirin from aloxiprin in buffer solns of pH 2-8 are lower than those of aspirin, particularly in more acid buffers.
Therap-Cat: Analgesic.
Keywords: Analgesic (Non-Narcotic).
alpha-(alpha-Aminopropyl)benzyl Alcohol alpha,alpha,beta-Trichloro-n-butyraldehyde alpha1-Antitrypsin alpha1-Sitosterol alpha-Acetylbutyrolactone

Systematic (IUPAC) name
aluminum 2-acetyloxybenzoate hydroxide
Clinical data
AHFS/ International Drug Names
Legal status  ?
CAS number 9014-67-9
ATC code B01AC15 N02BA02
PubChem CID 3032790
ChemSpider 2297682 YesY
KEGG D07421 YesY
Chemical data
Formula C18H15O9 
Mol. mass 402.288 g/mol
 YesY (what is this?)  (verify)

Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders.[1] It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.[1] It is a chemical compound of aluminium hydroxide and aspirin.[2][3]